Skip to main content
REMED CO.,LTD. logo

REMED CO.,LTD. — Investor Relations & Filings

Ticker · 302550 ISIN · KR7302550009 KO Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2025-03-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 302550

About REMED CO.,LTD.

https://www.remed.kr/en/

REMED CO.,LTD. is a medical device company specializing in the research, development, and manufacturing of electronic medication, also known as electroceuticals. The company focuses on providing non-invasive treatment solutions for intractable brain diseases, rehabilitation, and pain management. Its core technologies include transcranial magnetic stimulation (TMS) for neural modulation, as well as advanced electromagnetic stimulation, shockwave, and laser therapies. REMED produces both complete medical systems and essential core components, positioning itself as a provider of differentiated solutions in the medical technology sector.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in share ownership, and collateral agreements (pledges) of major shareholders and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for REMED Co., Ltd. It contains the agenda for the 22nd Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the meeting details and agenda items, which falls under the Proxy Solicitation & Information Statement category.
2025-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Proxy Solicitation Reference Document) and contains detailed information regarding the upcoming Annual General Meeting (AGM) of the company 'Remed'. It includes the meeting date, agenda items (such as approval of financial statements, election of directors, etc.), and instructions for shareholders to exercise their voting rights via proxy, electronic voting, or in-person attendance. This document is a standard proxy solicitation statement used to request shareholder votes for an AGM.
2025-03-11 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by the company Remed. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the approval of financial statements, election of directors, and remuneration limits. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of meeting details and agenda items, which falls under the 'Proxy Solicitation & Information Statement' category.
2025-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in shareholding, and collateral agreements (stock-backed loans) of major shareholders and their special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Remed) announcing a significant change (over 30%) in revenue or profit structure. This is a standard regulatory disclosure requirement in the Korean market (KRX) for listed companies to report preliminary financial results before the final audit is completed. Since it provides key financial highlights (revenue, operating profit, net income) and explains the reasons for the change, it fits the definition of an Earnings Release (ER). FY 2024
2025-02-19 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.